atypia underwent immediate excision: 5/9 (56%) were benign, 1/9 (11%) had atypical ductal hyperplasia and 3/9 (33%) had invasive carcinoma (pure mucinous or mucinous features). Overall, a total of 4/32 (13%) cases of MLL were upgraded to carcinoma, 3 of which were initially diagnosed on ultrasound core biopsies. Conclusions: None of the patients in this series with benign MLL on core biopsy had invasive carcinoma on excision. However, 16% had atypical ductal hyperplasia and 5% had ductal carcinoma in situ. Patients with MLL and atypical ductal hyperplasia or detached atypical cells on core biopsy were more likely to have invasive carcinoma on excision. These findings suggest that core biopsy findings may identify patients at the highest risk for upgrade to carcinoma on excision but validation in larger studies is required. (1/12), 100.0%(14/14), 100.0%(8/8). The expression was significantly higher in SpCC and MPC patients than that in ICONST and SCC patients (P<0.0001). The expression of Slug and Twist were negatively correlated with the expression of E-cadherin, while positively correlated with vimentin expression (P<0.05). Conclusions: SpCC and MPC patients displayed lower expression of epithelial marker (E-cadherin), higher expression of EMT-related transcription factors (slug, twist) and mesenchymal marker (vimentin), which indicated the role of EMT in MPC and SpCC. Slug and twist may regulate the expression of vimentin and downregulate the expression of E-cadherin in TNBC. Ya-Zhen Zhu, Dan Lu, Maruja E Lira, Qing Xu, Yunzhi Du, Jianghong Xiong, Mao Mao, Hyun Cheol Chung, Guangjuan Zheng. Guangdong Provincial Hospital of Traditional Chinese Medicine (GPHTCM), Guangzhou, China; WuXi AppTec, Shanghai, China; Pfizer Oncology, San Diego, CA; Yonsei University College of Medicine, Seoul, Korea. Background: Human epidermal growth factor receptor 2 (HER2) is a key driver of tumorigenesis, and over-expression as a result of HER2 gene amplification has been observed in a number of solid tumors. Recently HER2 has become an important biomarker for the monoclonal antibody treatment of HER2-positive metastatic breast and advanced gastric cancer. The HER2 targeting antibody Trastuzumab treatment requires accurate measurement of HER2 levels for proper diagnosis. Droplet digital PCR (ddPCR) with highly direct, precise and absolute nucleic acid quantification could be used to detect HER2 amplification levels. The aim of the present study was to evaluate a robust, accurate and less subjective application of ddPCR for HER2 amplification levels and test the assay performance in clinical formalin-fixed paraffin-embedded (FFPE) breast and gastric carcinoma samples. Design: Genomic DNA from HER2 amplified cell line SK-BR-3 was used to set up the ddPCR assays. The copy number of HER2 was compared to the chromosome 17 centromere reference gene (CEP17), expressed as HER2:CEP17 ratio. Genomic DNAs of FFPE specimens from 145 Asian patients with breast and gastric carcinomas were assayed using both standard methods, immunohistochemistry (IHC) and/or fluorescence in situ hybridization (FISH), and ddPCR. Results: Based on 145 clinical breast and gastric carcinoma cases, our study demonstrated a high concordance of ddPCR results to FISH and IHC. In breast cancer specimens, the ddPCR results had high concordance with FISH and IHC defined HER2 status with a sensitivity of 90.9% (30/33) and a specificity of 100% (77/77). In gastric cancer specimens that were concordant in both FISH and IHC, our assay was 95.5% concordant with FISH and IHC (21/22). Conclusions: ddPCR has the advantage of automation and also allows levels of HER2 amplification to be easily evaluated in large numbers of samples, and presents a potential option to define HER2 status. Results: In the 3 AS cases, we studied-and sought therapeutic targets in-selective molecular pathways that may be involved in the transformation of benign to malignant endothelium. The proteins Akt/mTOR, STAT 3, COX-2, and CD44 were expressed in all lesions. H&E staining showed thickened intima with calcified atherosclerotic lesions, and elastin staining showed diminished elastin fiber, medial degeneration, high-grade sarcoma, high N/C ratio, numerous atypical mitoses, and large areas of tumor necrosis. IHC results were strongly positive for vimentin, focally and unevenly positive for CD 31, and negative for pancytokeratin, CK-7, CK-20, calretinin, D-2-40, CD-45, S-100, MA, and CD 34; 95% of tumor cells were positive for Ki-67. The meningitis patient was anxious, tachypneic, hypothermic, paraplegic, and leukopenic (3.1k/cmm) after aortic repair. CSF showed RBC 96,250, WBC 4100 (93% PMN), glucose <1, protein 584, and visible gram-negative rods. MRI showed small left cerebellar and intraventricular hemorrhage; CSF, blood, and urine cultures grew Klebsiella pneumoniae. Conclusions: These cases contribute to the body of knowledge regarding these unusual perioperative proximal and distal complications, whether immediate or delayed, helping reveal the spectrum of disease that may arise in vasculature tissues, either spontaneously or after synthetic-graft placement. To manage these unusual complications properly, surgeons should take timely and adequate biopsies from any ambiguous vascular reconstructive lesions for histopathologic study. 
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Human Plaque-Aortic Ring Co-Culture: A Novel Assay for the Study of Atherosclerosis-Induced Angiogenesis Alfred C Aplin, Ted Kohler, Roberto Nicosia. University of Washington, Seattle, WA; VA Puget Sound HCS, Seattle, WA. Background: Atherosclerosis is a major cause of morbidity and mortality worldwide. Progression of atherosclerotic plaques into vulnerable lesions is often associated with angiogenesis which contributes to plaque growth, inflammation and hemorrhage. Although angiogenesis is recognized as an important contributor to the complications of atherosclerosis, the mechanisms of plaque-induced angiogenesis are poorly understood. Lack of adequate experimental models has significantly limited progress in this field. Design: Human plaques obtained from carotid endarterectomy or leg amputation procedures were co-cultured in collagen gels with rings of rat aorta which served as readout of plaque angiogenic activity. Angiogenesis was quantified by counting microvessels sprouted from aortic rings over time. The cellular composition of the outgrowths was evaluated by immunohistochemistry. The growth factor/cytokine secretome of human plaques was analyzed by immunochemistry. Antibody blocking experiments were used to define the role of plaque-derived growth factors in the angiogenic response. Results: Human plaque explants cultured alone failed to produce an angiogenic response except for isolated endothelial sprouts in rare explants. However when cocultured with rat aortic rings, plaque explants markedly stimulated angiogenesis from the aortic wall. The angiogenic outgrowth was composed of endothelial cells, pericytes, macrophages and mesenchymal cells. Analysis of the plaque secretome demonstrated heterogeneity of growth factor/cytokine production by different plaques. Blocking antibody experiments showed that targeting of individual growth factors such as vascular endothelial growth factor or tumor necrosis factor alpha failed to effectively suppress angiogenesis. Conversely ablation of adventitial macrophages from the aortic rings markedly reduced the angiogenic response. Conclusions: Human atherosclerosis-induced angiogenesis can be studied ex vivo by co-culturing plaque explants with rat aortic rings. Our results suggest that human plaque-induced angiogenesis is regulated by a redundant system of growth factors and cytokines and significantly influenced by adventitial macrophages. This model may prove useful to identify molecular pathways that initiate angiogenesis which can be targeted pharmacologically toward the goal of stabilizing atherosclerotic plaques and preventing the life-threatening complications of atherosclerosis.
Unique Insights into Cardiac Metastases and Tumor Biology from a Cancer Center's Rapid Research Autopsy Program
Prashant Bavi, Hamidreza Sharifzad, Qian Yang, Leslie Oldfield, Anthony Joshua, Jagdish Butany, Michael H Roehrl. University Health Network, Toronto, ON, Canada; Memorial Sloan Kettering Cancer Center, New York, NY. Background: Targeted therapies may be inducing selection pressure where unique tumor clones evolve with a propensity for unusual clinical presentation like cardiac metastases. Metastases to the heart are far more common than primary cardiac tumors. Here, we study cardiac metastases from our comprehensive rapid research autopsy program. Design: 105 patients who had consented to undergo directed rapid ("warm") autopsies have been studied. We investigated the extent of metastatic spread with an emphasis on cardiac metastases by focusing on the following aspects: (1) Tumor kinetics by integrating radiographic imaging findings and tumor burden; (2) number of metastases, size, and location; (3) clinical symptoms; (4) genome sequencing, transcriptomics, and proteomics of selected cases. Results: The incidence of cardiac metastases in our cohort was 21.9% (23/105), significantly higher than previous reports. Patient age ranged from 25 to 86 years (median, 64 years); gender distributions was 15 males and 9 females; histology: 13 carcinomas (GI and lung mostly), 6 melanomas, 3 leukemias/lymphomas, and 1 sarcoma. The weight of the heart ranged from 180 to 560 g (median, 335 g); size of cardiac metastases ranged from 0.3 to 40 mm (median, 5 mm) and number of metastases: solitary (n=5) and multiple (n=18). The median time from last imaging to autopsy was 36.5 days (25%-75% IQR, 20.7-76.0). There was significant underestimation of cardiac metastases at last radiologic imaging in virtually all patients; only two had documented cardiac lesions at imaging. Of these 23 patients, 8 (33.7%) were on clinical trial, 14(60.8%) received chemotherapy and or radiation, and 2 (8.6%) did not receive any treatment. Whole genome sequencing, RNASeq, and mass spec proteomics have been carried out successfully on all metastatic tumor sites from 2 rapid autopsy cases. Comparative whole genomes/exomes, RNAseq, and proteomics from multiple metastatic sites in pancreatic cancer showed that heart metastases clustered as distinct entities on a Jensen-Shannon (JS) dendogram. Conclusions: (1) A very high incidence of cardiac metastases was observed.
(2) Cardiac metastases were molecularly distinct from other solid organ metastases. (3) Underestimation of cardiac metastases by radiology is common. (4) With expected continued therapeutic improvements, metastases to the heart if not diagnosed and treated, may prove to be a limiting factor in improving long-term survival.
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Clinicopathologic Experience with Mitral Valve Repairs Using CorMatrix ECM® Technology Siddharth Bhattacharyya, Shiguang Liu, Nirag Jhala, He Wang. Temple University Hospital, Philadelphia, PA. Background: Mitral regurgitation is a common complication of myocardial infarction, and is associated with significant mortality and morbidity. Clinical evidence suggests that mitral valve repair has advantages over mitral valve replacement in both morbidity and mortality reduction. Newer options for repair include the use of artificial biomaterials. CorMatrix is an organic and acellular extracellular matrix, which is harvested from porcine small bowel submucosa. CorMatrix acts as a tissue scaffold, and is intended to promote neo-vascularization and remodeling to replicate normal tissue function. Early studies have found CorMatrix to be suitable for mitral valve repair, with excellent valvular function post-operatively. Our purpose is to present data on our institutional experience with the use of CorMatrix for mitral valve repair. Design: At our institution in 2013-2014, CorMatrix material was utilized during mitral valve repair surgery for eight patients with severe mitral regurgitation. The patient group consisted of two males and six females, ages ranging from 34 to 78 years. One patient had a history of rheumatic heart disease, and the remaining patients had histories of hypertension among other comorbidities. Four patients eventually developed recurrent mitral valve regurgitation requiring repeat intervention, and in some cases valve replacement. The time to graft failure ranged from 4-14 months. Native valve tissue and graft sections were submitted for histologic examination. Results: Histologic examination in all cases showed acellular graft material associated with a moderate to marked lymphoplasmacytic inflammatory infiltrate with focal acute inflammation and fibrinoid necrosis. Two cases showed marked granulomatous inflammation with multinucleated giant cells. Focal areas of fibroblastic proliferation and neo-vascularization were noted. However, no evidence of new intimal formation or remodeling was seen in any case. Immunohistochemical staining for CD68 and CD163 showed a predominant M1 macrophage phenotype, consistent with a proinflammatory response. Conclusions: While our sample size is small, our clinical experience shows a failure rate of 50% when using CorMatrix for mitral valve repair. Graft failure in each cases occurred between 4-14 months. Histologic sections of graft material show significant chronic inflammation with no evidence of remodeling. Our evidence suggests that CorMatrix is not a suitable material for mitral valve grafts.
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Apolipoprotein A-IV Associated Cardiac Amyloidosis Melanie C Bois, Surendra Dasari, Jason D Theis, Julie Vrana, Martha Grogan, Angela Dispenzieri, Paul J Kurtin, Joseph J Maleszewski. Mayo Clinic, Rochester, MN. Background: Apolipoprotein A-IV (Apo AIV) is known to co-deposit with other amyloid subtypes, and has been found to be the primary constituent in some cases of renal amyloidosis. However, cases of cardiac amyloidosis solely attributable to Apo AIV amyloid (AApoAIV) have not been described. Herein, we describe clinical and histopathological characteristics of cardiac AApoAIV, a novel type of cardiac amyloid. Design: Tissue registry archives at Mayo Clinic (Rochester, Minnesota) were queried for cases of cardiac amyloidosis typed as AApoA4 by liquid chromatography tandem mass spectrometry (2006) (2007) (2008) (2009) (2010) (2011) (2012) (2013) (2014) (2015) . Extent and pattern of amyloid deposition were assessed. Dominant and coexisting deposition patterns were classified as vascular (obstructive or non-obstructive), interstitial (nodular, discrete pericellular, or dispersed pericellular), and endocardial. Salient clinical information, epidemiological data, and imaging features were abstracted from the clinical record. Results: 12 patients (pts; 10 men) with cardiac AApoA4 were identified with a mean age of 75 years (range, 64-89) . 4 autopsy cases and 4 surgical specimens (total=8) were available for histopathologic and clinical review; 4 consultation cases had epidemiologic information only. 7 of 8 patients had symptomatic cardiac dysfunction, 4 of which carried a diagnosis of hypertrophic cardiomyopathy and 3 were attributed to coronary artery disease. 6 pts had conduction system abnormalities. Left ventricular ejection fraction was preserved in the 7 cases with echocardiographic data (median 59%, IQR 54-67%).
7 pts had renal insufficiency. Of available cases (n=8), the dominant deposition pattern was vascular in 4 cases and nodular interstitial in 4. Amyloid extent was marked in 2 cases, moderate in 4, and mild in 2 cases. Obstructive vascular amyloid and interstitial involvement were present in all cases. 3 cases had focal endocardial involvement. All autopsy cases demonstrated small vessel involvement in other visceral organs and prominent medullary renal deposits. Conclusions: AApoAIV is a rare, novel subtype of cardiac amyloidosis. Vascular tropism and relatively large nodular interstitial deposits appears to be common histopathologic features of cardiac AApoAIV. Atypical clinical presentations, where amyloid was not a primary diagnostic consideration, are present in at least half of the cases. Limited autopsy experience suggests relatively widespread vascular involvement in most organs systems and renal medullary deposits in the setting of AApoAIV amyloidosis. Molecular genetic analysis of the ApoAIV gene in a select group of these patients is ongoing.
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Endothelial Cell Chimerism in Human Cardiac Allografts Gregory A Fishbein, Maristela L Onozato, Adriana Luk, Michael M Givertz, Robert F Padera, Jr., Anthony J Iafrate, Richard N Mitchell. Brigham and Women's Hospital, Boston, MA; Massachusetts General Hospital, Boston, MA. Background: It is unknown to what degree circulating endothelial cells (CEC) replace donor endothelium in cardiac allografts; perioperative ischemic injury or rejection may increase this potential. Moreover, as endothelial cells are the interface between the host immune system and the allograft, replacement of donor endothelium may protect against acute cellular rejection (ACR) and/or antibody-mediated rejection (AMR). Design: Thirty-nine endomyocardial biopsies of 12 male recipients of female hearts, performed at 1, 3, 6, and 12 months post-orthotopic heart transplant (OHT) were evaluated for ACR and AMR by one of three pathologists. Endothelial cells were segregated as donor or recipient based on detection of X and Y chromosomes by fluorescence in situ hybridization. Endothelial cells were identified by positive fluorescent immunoreactivity to CD34 antigen and negative reactivity to CD45 antigen; such cells exhibiting two X chromosomes were designated as donor, while those with one X and one Y chromosome were designated as recipient. Results: An average of 103 endothelial cells per biopsy were analyzed. Endothelial cell chimerism, defined as the percentage of endothelial cells with X and Y chromosomes, at 1, 3, 6, and 12 months post-OHT can be seen in figure 1.
Over the 12 months, all subjects had at least one biopsy showing mild or moderate ACR (ISHLT 1R or 2R); three had at least one episode of pathologic AMR. Seven subjects showed an overall increase in chimerism over time, one of whom developed AMR. Five showed an overall decrease, two of whom developed AMR. Three subjects showed no chimerism 1 month following OHT; all three had at least one episode of moderate ACR; one had multiple biopsies positive for AMR. All biopsies following episodes of rejection showed an increase in chimerism. Conclusions: Our data indicate that within one month post-OHT the average chimerism is 1.9% (0-3.9%). Six months post-OHT, up to 6% of donor endothelial cells were replaced by CEC of recipient origin. This number increases following episodes of ACR. Most individuals showed an increase in chimerism over time. AMR was more common in the minority of individuals who experienced decreasing chimerism over time, suggesting that replacement of donor endothelial cells may be protective. Background: Myocarditis, inflammation of the heart muscle, may be caused by infection (most often viral), autoimmunity, or chemical exposure. Clinical symptoms are also variable, with some patients, regardless of etiology, experiencing life threatening acute illness, others suffering from chronic disease, and still others who never present clinically. The risk factors for developing different patterns of disease are poorly elucidated, but preclinical and limited clinical studies have implicated a role for the signalling cascade involving neuregulin 1 (NRG1), epidermal growth factor related receptor ERBB4, and presenilin 1 (PSEN1). This study aims to characterize the same signalling pathway in archival human tissue specimens from patients with a diagnosis of myocarditis. Therefore it's hypothesized that variable expression and function of the NRG1-ERBB4-PSEN1 signaling axis are associated with different clinical manifestations of myocarditis. Design: Nine (9) cases of myocarditis and one (1) normal control were identified from the Cardiovascular Tissue Registry in the Centre for Heart Lung Innovation. Using archival tissue from the left ventricle of each case, protein expression levels, cellular localization, and post-translational modifications of NRG1, ERBB4, and PSEN1 were evaluated using immunohistochemistry, immunofluorescence, and western blotting. Results: NRG1, ERBB4, and PSEN1 were expressed at higher levels in the majority of myocarditis cases compared to the normal heart tissue. All three proteins accumulated in the nucleus of myocarditis hearts, while PSEN1 was also detected in extracellular protein aggregates (plaques) in myocarditis cases, while ERBB4 also accumulated in lysosomes. ERBB4 and PSEN1 were found to co-localize in and out of the nucleus. Western blots showed NRG1 as 50 kDa, ERBB4 showed 80 and 120 kDa cleavage products, PSEN1 was detected as a 47 kDa holoprotein, as well as two PSEN1 aggregates approximately 100 kDa and between 47 and 75 kDa ranges. Conclusions: Preliminary studies show a distinct difference in expression patterns of NRG1, ERBB4, and PSEN1 in cases of myocarditis as compared to normal heart controls. Further experiments are likely to establish patterns of expression that correlate with disease severity and temporality. These data may provide diagnostic and therapeutic guidance with respect to the different clinical manifestations of myocarditis.
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Long Background: Surgical bioprosthetic aortic valves (SAV) offer many advantages to patients with aortic stenosis but pathologic studies have reported limited durability of these devices due to calcific and non-calcific deterioration over time. The long-term pathological changes observed in Edwards SAPIEN transcatheter aortic valve (ESTAV) following implantation have not been well characterized. Design: From our ESTAV pathology registry, 29 cases (mean age 82.6±7.9 years, 52% men) with ESTAV were included, which were removed either at autopsy or surgery. Valve leaflets were embedded in paraffin and stained with hematoxylin and eosin (HE), Movat's pentachrome (MO) and Von Kossa (VK). Neointima, thrombus, inflammation, structural changes (degeneration), and calcification of leaflets were evaluated histologically and semi-quantitatively graded for both aortic and ventricular surfaces of the leaflet (Score 0-4). Pathological findings were assessed by duration (≤30 days; 31 days-1 years; 1-3 years; >3 years) of implant. .47). Calcification was observed in two valves > 3 years: one valve (4 years) showed early microcalcifications at a leaflet commissure; a second valve was explanted for aortic stenosis due to calcification at 5 years post implantation. Conclusions: All explanted valves demonstrated intact leaflets with mild inflammation, thrombus and neointima up to 5 years. Degeneration was minimal and stenosis due to calcification was seen in one valve at 5 years, a complication also reported in SAV of similar duration. The pattern of calcification in ESTAV recapitulated that reported for SAV with early microcalcifications found predominately at commissures (region of high stress). Overall, valve leaflet durability for ESTAV appears to be comparable to SAV. In BMS, restenosis with underlying neoatherosclerosis was observed only >3 years, and neoatherosclerosis accounted for 38% of BMS restenosis >3 years. In contrast, both 1 Because they are associated with catastrophic CV events, identification of those atrisk is paramount. While a strong family history can prompt screening, post-mortem genetic testing is often lacking. Furthermore, ideal specimens (i.e. whole blood (WB)) often are note retained at autopsy. Ubiquitous use of formalin-fixed paraffin embedded tissue (FFPET) in autopsy makes it an ideal source for interrogation; however its use in traditional sequencing is limited owing to genomic integrity. Targeted next generation sequencing (NGS) technology offers the ability to circumvent such limitations. The primary aim was to evaluate the efficacy of testing FFPET for heritable CV disorders using NGS. Design: Paired FFPET (heart) and blood (WB or dried blood spot (DBS)) samples were obtained from 13 patients. 7 were random autopsy samples, 3 were autopsies with clinical phenotype of a heritable CV disorder but unknown genotype, and 3 were surgical samples from patients with genotype-confirmed hypertrophic cardiomyopathy (HCM) on blood. Extracted genomic DNA underwent Agilent SureSelect targeted capture of 101 genes associated with CP, CM, and CTD, followed by sequencing on the Illumina MiSeq. Quality metrics were compared. Variants were classified by consensus.
Results: In quality comparisons of 10 cases using the CM discovery panel (63 genes), there were no significant differences between FFPET, WB and DBS in average percent mapped reads (60 vs 55 vs 60%), average depth of coverage (1259 vs 1425 vs 1490X), and Phred quality scores (all >30). Analysis of surgically derived FFPET from HCM patients, confirmed pathogenic mutations in TPM1, MYH7, and MYBC3, previously detected on WB. In the 3 autopsy cases with unknown genotype, testing on FFPET identified pathogenic mutations in FBN1, RAF1, and MYBC3, consistent with the clinical phenotype of Marfan syndrome, Noonan syndrome, and HCM, respectively. There was 100% concordance for all genotype calls, with no false positives or false negatives.
Conclusions:
The results of this validation study show similar performance characteristics for NGS of DNA derived from FFPET (≤17 years old), WB, and DBS, in the evaluation of inherited CV disorders. Such has important implications for molecular genetic testing when only FFPET is available. Additionally, interrogation of such tissues has important implications for extensive genotype-phenotype correlation in archival tissue, which is currently ongoing.
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Cardiac Angiosarcoma: Histopathologic, Immunohistochemical, and Molecular Genetic Analysis of 10 Cases Charles Leduc, William R Sukov, Jeannette G Rustin, Joseph J Maleszewski. Mayo Clinic, Rochester, MN. Background: Angiosarcomas (AS) are the most common type of primary cardiac sarcoma with differentiation. Approved targeted therapies are lacking, and response to conventional therapies is suboptimal, leading to poor overall survival. Recurrent copy number variations and/or mutations have been identified in extracardiac AS, however these have yet to be investigated thoroughly in those arising primarily in the heart. This study aims to further define the molecular profile of cardiac AS, and correlate such with histopathologic features, clinical features, and course. Design: Tissue registry archives at Mayo Clinic (Rochester, MN) were queried for cases of cardiac AS (1995 AS ( -2014 . Cases with sufficient tissue for molecular genetic testing were retained. Demographics and clinical follow-up were abstracted from the clinical record, histologic parameters were reviewed, and immunohistochemistry for cytokeratin AE1/AE3 and vascular markers (CD31, CD34, ERG, FLI-1) was performed. DNA was extracted from formalin-fixed paraffin-embedded tissue, and copy number and loss of heterozygosity analysis was carried out with a whole genome single nucleotide polymorphism-based platform (OncoScan). Results: 15 cases were identified, 10 of which had sufficient tissue for molecular testing. Mean age was 47.3 years, male:female ratio was 1.5:1, and median survival was 5.2 months (1-60 mos). There was no thoracic irradiation in the cohort. The majority (7/10) occurred in the right atrium, and average size was 6.3 cm (2.5-9.8). All cases had necrosis and the mean mitotic count was 13/10 hpf. 13 cases had spindle cell morphology, 1 epithelioid and 1 mixed. ERG was the most sensitive vascular marker (diffuse in all cases), and 4/10 cases were at least focally positive for CK AE1/AE3. The most common genetic alteration was polysomy 8 (n=8), followed by polysomy 4 (n=4) and gain of 1q (n=4). In no cases was there specific amplification of MYC (8q24). Gain of 1q was accompanied by polysomy 8 in all 4 cases, and was associated with a trend towards longer survival compared to cases without gain of 1q (31.8 vs 4.4 mos, p=0.065, Log Rank). Conclusions: This is the first study to have comprehensively studied cardiac AS form a molecular standpoint. Recurrent chromosomal aberrations were identified and include polysomy 8, polysomy 4, and gain 1q. The lack of MYC amplification is in keeping with the strong association of this aberration with radiation. While the mechanism remains unclear, our data shows that 1q gain may be associated with prolonged survival, which suggests possible prognostic role of molecular testing in cardiac AS.
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How Background: This study sought to assess the pathologic markers to evaluate the irreversibility of congenital heart disease associated pulmonary hypertension (CHD-PAH). Design: Tweenty-eight patients with CHD-PAH were divided into two subgroups of reversible pulmonary hypertension (RPAH) and irreversible pulmonary hypertension (IPAH) according to postoperative mean pulmonry artery pressure (MPAP). Pulmonary vascular lesion was analyzed according to Wagenvoort's methods. Mean medium thickness percent (%MT), mean medium area percent (%MA) and pulmonary arteriole density were measured by quantitative morphometric techniques. The immuonactivities of transgelin and filamin A were analyzed by immunohistochemistry. Results: Of all 28 patients, 24 were RPAH and 4 were IPAH. Of all 24 patients with RPAH, 13 biopsies (54.2%, 13/24) had pulmonary vascular lesion of grade 0, 9 (37.5%, 9/24) with grade 1 and 2 (8.3%, 2/24) with grade 2. Of 4 IPAH, 1 biopsy had lesion of (25%, 1/4) grade 1, 1(25%, 1/4) with grade 2 and 2 (50%, 2/4) with grade 3. Both preoperative and postoperative MPAP were higher in IPAH patients than that in RPAH patients (53.3±23.4mmHg vs 34.1±12.7mmHg, p=0.020 and 35.0±8.8mmHg vs 17.8±3.9mmHg, p<0.001). Compared to those patients with pulmonary vascular lesion of grade 0 and 1, the preoperative MPAP in the patients with grade 2 and 3 had no significant difference, but the postoperative MPAP was higher (p<0.05 or 0.01). 
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Characterization of LVAD Ventricular and Aortic Interfaces: Potential Role in Device Thrombosis Daniel Pelletier, Stanley J Radio. University of Nebraska Medical Center, Omaha, NE. Background: Left ventricular assist devices (LVAD) have become increasingly common therapy for heart failure patients as a bridge to transplant or destination therapy. Thromboembolic events are a significant cause of device failure, morbidity, and mortality. Limited information exists on the healing of LVAD connections with native hearts, and their contribution to thrombus formation. Design: Explant and autopsy specimen LVADs from 65 patients (M=52, F=13, ages 20-75 yrs, ave=54.8 yrs) with implant duration between 2 weeks-22 months were available for review. For each specimen, the length and % circumference of LV cannula fibrous ongrowth (FG) exterior and interior, presence and degree of luminal obstruction, aortic graft neointima length and % circumference, and presence of thrombus (inflow/ outflow cannula, device housing) were recorded. Histologic exam was performed on each device interface. Results: FG was present on 100% of exterior LV cannulae, ranging from 3-20 mm (avg 12). FG cannula circumference was over 50% in 83.1% of specimens. FG on the LV cannula lumen ranged from 1 to 15 mm (avg 5.1), with 85.2% of specimens displaying some degree of luminal FG. Luminal obstruction by FG was present in 43.1% of specimens. 31% of specimens had obstruction between 1-10% of luminal area, with 8.6 and 3.4% of specimens displaying 11-25% and 26-50% obstruction, respectively. Neointima of the aortic graft was present in 93.5% of explants and ranged from 1-20 mm (avg 8.4) and involved >50% of the circumference in 58.7% of devices. Intimal reaction of the native aorta was present in 31%, and ranged from 1-8 mm (avg 2.8) with 12.5% involving >50% of the circumference. Thrombus was present in the LVAD pump of 24.5% of specimens, ventricular cannula outlet in 1.64%, and aortic graft outlet in 12.2%. The healing reaction at the LV cannula/LV site consisted of chronic inflammation (lymphocytes, histiocytes, foreign body giant cells, and plasma cells) and granulation tissue with variable degrees of fibrosis. The neointima at the aortic anastomosis consisted of collagen or fibromyxomatous matrix with smooth muscle cells lined by endothelial cells. Conclusions: Fibrous ongrowth was present in all patients and tended to increase with implant duration. Such ongrowth led to at least some luminal obstruction in 43%, including greater than 25% luminal area obstruction in 2 devices. Thrombus was present at various locations in 26% of patients. In our study, 47% of patients with thrombus had some degree of LV cannula luminal obstruction, suggesting it may play a role in the development of thrombus.
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Sudden Cardiac Death with Structurally Normal Heart: ECG Tracing and Molecular Autopsy as a Guide for Conduction System Investigation Kalliopi Pilichou, Federico Migliore, Marco Cason, Stefania Rizzo, Rudy Celeghin, Emanuele Bertaglia, Elisabetta Lazzarini, Elisa Carturan, Marialuisa Valente, Gaetano Thiene, Cristina Basso. University of Padua, Padua, Italy. Background: Sudden cardiac death (SCD) with normal heart can occur in the setting of inherited ion channel diseases. Among these, Lenégre disease (progressive atrioventricular block) is characterized by structural changes of the conduction system and mutations in the α subunit of the cardiac sodium channel (SCN5A). Design: Autopsy with gross and histologic examination of the heart of the index case was carried out including molecular autopsy through screening a panel of 150 cardiacrelated genes (Nextera custom panel, MiSeq, Illumina). Mutation pathogenicity was determined by in silico prediction algorithms and filtering in exome variant server, dbSNP, HGMD, ClinVar, LOVD database. Detailed conduction system investigation by serial section technique was performed guided by ECG and genetic findings. Cascade genetic screening of family members with clinical investigation in mutation carriers.
Results: A 35-years old asymptomatic male died suddenly during sleep. Post-mortem examination excluded extracardiac causes of SCD as well as the absence of structural abnormalities in the working myocardium. Personal clinical history re-assessment revealed a 'coved-type' ST segment elevation on right precordial leads with PQ prolongation (220 msec) in a patient's ECG performed during blood donation, compatible with Lenégre disease. Genetic screening identified a mutation in exon 22 (c.3673 G>A, E1225K) of SCN5A (NM. 198056.2) gene, defined as "likely to be pathogenic" by in silico tools and linked to progressive atrio-ventricular block. Detailed conduction system investigation showed severe fibrosis of the bifurcating His and proximal bundles with sclerotic interruption of the left bundle branch. Cascade genetic screening detected 5 additional family mutation carriers, and provoked electrical stimulation unmasked ECG abnormalities in 2 of them. Conclusions: Conduction system investigation is rarely performed in SCD due to difficult interpretation of histologic findings in the absence of clinical data. Conduction abnormalities on ECG and positive molecular autopsy are of help in selecting cases to be investigated by serial section technique.
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Myocardial Background: Pathological analysis of left ventricular capillary density (CD) after heart transplantation, as well as the relationship of CD with left ventricular function, is lacking. Rare data using right ventricular endomyocardial biopsies suggest capillary rarefaction after heart transplant. Design: We analyzed the relationship between myocardial CD and the duration of implantation using ventricular tissue generously obtained from explanted hearts at autopsy. The retrospective analysis involved 20 subjects including 14 orthotopic heart transplantation (OHT) subjects and 6 control subjects without OHT. Subjects with OHT were divided into short-term (within 6 months after OHT, n=4) and long-term groups (more than 6 years after OHT, n=10). CD was evaluated after CD31 staining, while ventricular fibrosis was analyzed after trichrome staining, using ImageJ software for the quantitative morphometric analysis. mRNA levels of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF) in ventricular tissue were measured by quantitative reverse transcription polymerase chain reaction. Results: CDs of left ventricles were significantly higher in the short-term group compared to the control group (1773+/-232 versus1007 +/-390 capillaries/mm 2 ; P=0.008) or the long-term group (1773+/-232 versus 1150 +/-389 capillaries/mm 2 ; P=0.010). No significant difference in CD was found between long-term and control groups. The changes of right ventricular CD showed a similar trend. There was no significant change of VEGF or bFGF mRNA levels in ventricular tissue between control, short-term and long-term groups. There was a significant increase in fibrosis of ventricular tissue in the long-term group compared to the control group (median [interquartile range (IQR)] = 5.51 [3.70, 15 .43] versus 2.12 [1.45, 2.18] %, P = 0.0043). No significant difference in fibrosis was found between short-term and control groups. There was no significant correlation between left ventricular CD, left anterior descending coronary artery (LAD) lesion and ventricular fibrosis. Conclusions: Our study revealed a significant increase in CD of left and right ventricles in transplanted hearts within 6 months after OHT; CD decreased thereafter to the levels in hearts without OHT. The mechanism of the early angiogenesis is under further investigation. No direct correlation between myocardial CD, LAD lesion and ventricular fibrosis was identified.
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Transcathether Background: Catheter ablation of the Atrio-ventricular junction (AVJ) followed by pacemaker implantation is used for atrial fibrillation therapy. The endocardial approach can be either from the right side or more rarely from the left side. Data about the ideal interventional anatomy of the tricuspid valve (TV) and the histologic features after successful ablation are missing. Design: A total of 100 human hearts were examined for the anatomic variability of the continuity between the anterior and septal TV leaflets. Hearts form patients with successful catheter abaltion of AVJ were studied by serial section techniques of the conduction system. Results: In 98% of cases, a continuity between the anterior and septal TV leaflets was found (3.8±2.9 mm). Four patients with atrial fibrillation had a previously successful catheter ablation.Tthree of them had a TV leaflets continuity. Ablation from the right side was successful in all except one requiring a left side approach. Conduction system investigation revealed fibrosis of the AV node and/or His bundle in each case with a right side approach, while extensive fibrosis of the ventricular septum crest and branching bundle but an intact AV node were observed in the setting of a left side approach.
Conclusions:
The anatomic variability of the antero-septal commissure of the TV can affect a successful AVJ ablation, since the continuity protects the AV node from ablation with a right side approach. In this setting, multiple shocks are required, seldom necessitating a switch to a left side approach. Atsuko Seki, Koji Chida, Akihiko Hamamatsu, Motoji Sawabe, Yoko Matsuda, Keisuke Nonaka, Shinichiro Ohkawa, Tomio Arai. Tokyo Metropolitan Geriatric Hospital, Itabashi, Tokyo, Japan; Kasumigaseki Clinic, Chiyoda, Tokyo, Japan. Background: The most common cause of AMI is believed to be the rupture of thin cap fibroatheroma (TCFA). Few data are available regarding the cause of AMI in the elderly. We hypothesized that a different mechanism was operative. Design: Formalin-fixed human coronary arteries from 884 patients (mean 81.2 yrs, 55.5% men) were serially examined at 5 mm intervals. Of those, 6.1% of patients had AMI (n=54). Cases with previous cardiac intervention (PCI/CABG) and OMI (n=97) were excluded. The culprit lesions were paraffin embedded, serially cut into 5-µm-thick sections, and stained with H&E, EVG, and Azan (46,111 sections). Twenty-four culprit plaques (LAD, n=11; LCX, n=6; RCA, n=7) were classified as erosion, rupture of TCFA (<65 µm Stenosis was severe in all groups; erosion (mean, 95.9%), calcified nodule (mean, 94.8%), rupture (mean, 89.2%), and stenosis (mean, 98.6%). TCFA was found in all rupture cases and one erosion case. Conclusions: Erosion was the most common culprit lesion in fatal AMI in the elderly. TCFA was present in only 20.8% of the culprit plaques. The different pathogenesis of AMI in the elderly suggests that other strategies might be necessary to prevent AMI in this age group.
Erosion Is More Common as a Cause of AMI in the Elderly: A Pathologic Study of Coronary Arteries in 884 Human Autopsy Cases
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C4d-Negative, DSA Positive Antibody-Mediated Rejection in Heart Allografts Kelly Smith, Karen Nelson. University of Washington, Seattle, WA; BloodWorks Northwest, Seattle, WA. Background: Antibody-mediated rejection (AMR) is a challenging clinical and pathologic diagnosis. Recently, within the renal transplant community, microvascular inflammation has emerged as a sensitive marker of AMR, and uncovered the existence of C4d-DSA+ AMR. The diagnostic criteria for C4d-negative antibody-mediated rejection in heart allografts has not been established. We evaluated the clinical, pathologic and laboratory data for for 122 allografts performed at our institution, in order to determine criteria to define AMR. Design: We reviewed pathology, laboratory and clinical data for 122 orthotropic heart transplant cases done between September 2008 and September 2014. These patients had undergone 563 biopsies, 346 immunopathologic studies and 703 DSA assays, using single antigen bead technology. Results: Out of 346 immunostains for C4d, we had 44 (13%) C4d+ biopsies. 25 (57%) C4d+ biopsies were from DSA+ patients. 47 (63%) of 75 biopsies from DSA+ patients were C4d-, and 3 were indeterminate. 43% of C4d+ biopsies were from DSA-patients. Out of 563 biopsies we had 30 (5.3%) biopsies with histologic findings suggestive of antibody mediated rejection (H+). 15 (50%) H+ biopsies were from DSA+ patients and 15 (50%) H+ biopsies were from DSA-patients. We had 3 (0.86%) biopsies that were H+ and C4d+, and all of these were from DSA+ patients. Conclusions: The majority of DSA+ patients have C4d negative biopsies. C4d-, DSA+ biopsies may represent: a prelude to C4d+ AMR, successful treatment of C4d+ AMR, subclinical AMR, or clinically relevant AMR. Future studies are needed to define histologic/immunopathologic features or other tests that will help diagnose clinically relevant C4d-AMR.
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Biochemical Signature of Antibody-Mediated Rejection in Cardiac Allograft Biopsies Imran Uraizee, Michael Walsh, Peter Nguyen, Aliya N Husain. University of Chicago, Chicago, IL; University of Illinois at Chicago, Chicago, IL. Background: Antibody-mediated rejection (AMR) in cardiac allograft recipients remains less well-understood than acute cellular rejection, is associated with worse outcomes, and portends a greater risk of developing chronic allograft vasculopathy. Diffuse immunohistochemical (IHC) complement 4d (C4d) staining of capillary endothelia in formalin-fixed, paraffin-embedded (FFPE) right ventricular (RV) endomyocardial biopsies is the current gold standard for diagnosis of immunopathologic AMR but serves only as a late-stage marker. Label-free biochemical imaging by infrared (IR) spectroscopy of FFPE RV tissue may facilitate identification of a unique biochemical signature of AMR. Design: From 23 FFPE RV tissue biopsies obtained during cardiac allograft rejection surveillance (11 negative for any type of rejection, 12 positive for immunopathologic AMR with diffuse IHC C4d endothelial staining), unstained 4mm sections were cut onto MirrIR low-e reflective slides for IR spectroscopic analysis. FFPE RV tissue biopsies from 11 native hearts without major diagnostic abnormality were also sectioned as a control group. IR absorption spectra of entire tissue sections were acquired and regions of interest (ROI) identified, including cardiomyocytes and endothelial cells. Extracted spectra were averaged across pixels within each ROI. Multivariate principal component analyses (PCA) were used to compare differences in absorption spectra among biopsies from each group. Linear discriminant analyses (LDA) were used to identify unique spectral classifiers. Results: Comparison of IR spectra derived from cardiomyocytes and endothelial cells demonstrated unique spectral features between the C4d positive and negative biopsies. PCA demonstrated that the C4d positive and negative biopsies could be discriminated and visualized to separate into distinct groups. LDA yielded spectral classifiers permitting accurate automated classification of biopsies.
Conclusions:
In cardiac allograft biopsies with immunopathologic AMR, IR spectroscopy reveals a biochemical signature unique to AMR compared to that of non-rejecting cardiac allografts and native hearts. Further work is ongoing to increase the number of patients and to determine whether a spectral signature preceding C4d deposition can predict later development of AMR. Jonathan Vaucher, Justine Turmel-Roy, Olga Sazonova, Sylvain Page, Sylvain Trahan, Christian Couture, Philippe Joubert. Institut Universitaire de Cardiologie et de Pneumologie de Québec, Quebec, QC, Canada. Background: Coronary angiography is the standard method for determining the site, extent and severity of coronary artery disease. Several publications have reported discordance between the degree of coronary artery stenosis as assessed by histologic evaluation when compared to angiography. Although angiography has inherent biases, histopathologic evaluation tends to overestimate the stenosis percentage owing to the relaxed state in which the coronary arteries are fixed and examined. The goals of this study were: 1) to achieve formalin fixation of hearts in conditions which simulate arterial systemic pressures by using a device of our own, 2) to determine if this method can reduce the overestimation of the degree of stenosis when compared to the passive immersion-fixation method. Design: Autopsy hearts were fixed, either by passive immersion (n = 30) or by intraaortic perfusion of formalin at 80-90 mmHg for at least 12 hours (n = 10). Coronary arteries were then dissected en bloc, serially sectioned and submitted for histology. Sections stained with Verhoeff von Gieson were digitized and the maximal percentage of stenosis was calculated by dividing the surface area of the residual lumen by the surface area delimited by the internal elastic lamina.
Formalin Perfusion-Fixation of Autopsy Hearts for a More Accurate Evaluation of Coronary Artery Stenosis
Results:
The results are summarized in table 1. The mean percentages of stenosis for each coronary artery was significantly lower in the perfusion-fixation group than in the immersion-fixation control group. 
Conclusions:
Our results suggest that perfusion-fixation reduces histopathological overestimation of stenosis severity compared to the passive fixation method. Further studies to evaluate which one of these two methods better correlates with the pre-mortem angiography are underway at our center. Jindong Wang, Theodore Vasiliadis, Eman Hamad, Xu Wang, Viren Patel, Jieliang Li, Xulei Liu, Nirag Jhala, He Wang. Temple University Hospital, Philadelphia, PA; Vanderbilt University, Nashville, TN. Background: Prolonged ventricular unloading with a left ventricular assist device (LVAD) or other continuous flow devices have been used significantly in recent years to treat severe heart failure. The use of LVAD has been shown to lead to myocardial recovery in some patients, indicating that some degree of cardiomyocyte regeneration can be induced by decreasing the external load. Furthermore, mitosis and cytokinesis were reported to increase significantly in the post-LVAD hearts. This study is aimed to determine the cellular response of human heart to the prolonged mechanical unloading by a LVAD. Design: Pre-and post-LVAD heart tissue samples were collected from 11 patients at the time of LVAD implantation and heart transplantation. The 11 patients included 2 females and 9 males with age ranging from 27 to 71 and averaging 57. Four patients had ischemic cardiomyopathy and seven patients had non-ischemic cardiomyopathy. All had no histologic evidence of active myocarditis. The duration of LVAD ranged from 1.5 to 56 months with an average of 10 months. The tissue was processed in the histology lab of Temple University Hospital for H&E and immunostaining. The capillary density was measured by ImageJ software on the CD31 immunostained slides. The preand post-LVAD samples were compared using the Wilcoxon signed rank sum test. The mRNA levels of basic fibroblast growth factor (bFGF) were measured by quantitative RT-PCR from paraffin-embedded formalin-fixed tissue. Results: Of the 11 matched pre-and post-LVAD tissue samples, 10 demonstrated an up to 167.1% increase in capillary density after the use of LVAD (range= 20.0-167.1%, 66.3+/49.5%). One showed a 30.1% decrease in capillary density (duration of LVAD=10 months). The increase of capillary density in post-LVAD cardiomyocytes is statistically significant (p=0.0098). The amount of changes in capillary density was not related to the duration of LVAD (p=0.69). There were no significant changes in the amount of bFGF mRNA between pre-and post-LVAD groups. Conclusions: Significant positive effects on the vascular architecture of human heart were observed by the prolonged ventricular unloading of LVAD. This improved vascularization of cardiomyocyte may play a role in the switch from a hypertrophic state to a hyperplastic state induced by decreasing the external load of the human heart.
Left Ventricular Assist Device Can Increase Capillary Density of Human Heart
Diagnostic Value of T helper Type 17 (Th17) Cells in Moderate Acute Cellular Rejection of Cardiac Allograft
Yinong Wang, Leland B Baskin, Daniel G Fontaine, Shuhong Liu, Christopher Naugler. Calgary Laboratory Services, University of Calgary, Calgary, AB, Canada. Background: A diagnosis of moderate acute cellular rejection (grade 2R) is clinically important since it triggers adjustment in the immunosuppressive regimen whereas mild acute cellular rejection (grade 1R) usually does not. However, myocyte damage, a required morphologic feature for diagnosis of grade 2R rejection can be difficult to ascertain since the morphologic spectrum of myocyte damage is wide and has subtle changes. Studies have shown a major source of discordance in the grading is the criteria used for the interpretation of myocyte damage. Thus, it is necessary to explore new ancillary studies such as immunohistochemistry to improve accuracy of the morphologic diagnosis of grade 2R rejection. Recent research data suggest that the IL-17 producing T helper type (Th17) cell plays a crucial role in the acute allograft rejection. Design: 25 cases of cardiac transplant biopsies with moderate acute cellular rejection were found in archives of Calgary Laboratory Services. The immunohistochemical stain for IL-17 was performed on the paraffin sections of the above biopsy specimens. The previous cardiac biopsy with diagnosis of mild acute cellular rejection from the same patient with the moderate acute cellular rejection was used as control. The Th17 cells were counted in the lymphocytic infiltrate regions. The data are expressed as number of cells per high power field (HPF). Results: As compared with mild acute cellular rejection, biopsies with moderate acute cellular rejection had significantly increased number of Th17 cells (2.99 ± 2.29 cells/ HPF vs 1.14 ± 1.50 cells/PHF, p<0.001). Conclusions: The Th17 cell infiltration in the cardiac allograft is associated with severity of cardiac acute cellular rejection. Evaluation the number of Th17 cells in the cardiac transplant biopsies might be helpful in assistance with diagnosis of moderate acute cellular rejection and improve diagnostic accuracy of moderate acute cellular rejection.
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Beta Amyloid Precursor Protein in Carotid Artery Plaque Macrophages: Correlation with Features of Plaque Stability Michael B Ward, Tyler A Jensen, Krishna Narra, Scott McNally, Dylan Miller. Intermountain Medical Center/ University of Utah School of Medicine, Salt Lake City, UT; University of Utah School of Medicine, Salt Lake City, UT. Background: Beta amyloid precursor protein (bAPP) is the amyloidogenic protein present in amyloid deposits of Alzheimer plaques and cerebral amyloid angiopathy. Its native function and activity (when properly folded and not produced in excess) are not fully understood, however bAPP is found in platelets and has been implicated in vascular inflammation and atherosclerosis. The aim of this study was to determine whether native bAPP (not amyloid) could be found in carotid plaques and if its presence or localization correlated with features of plaque instability. Design: Intact carotid endarterectomy specimens were obtained as part of an ongoing IRB approved radiology-pathology collaborative study. The samples were formalin fixed and decalcified. H&E and elastic stains were performed to allow for characterization of plaques and features of instability (soft/necrotic atheroma, intraplaque hemorrhage, thin fibrous cap, cap inflammation). Immunoperoxidase staining for bAPP (DAKO clone 6F/3D) was also performed and the stained sections reviewed. The localization of staining was recorded along with a semiquantitative assessment of staining intensity and abundance. Immunohistochemistry data was correlated with features of plaque instability using the Pearson correlation method. Results: 55 carotid tissue blocks from 35 patients comprised the sample population. The mean patient age was 69 years and 3 were women. 12 had ipsilateral strokes. 35 (64%) of the plaques showed features of instability. bAPP staining was limited to macrophages in a coarse granular cytoplasmic pattern, consistent with the reported phenomenon of macrophage phagocytosis of platelets expressing bAPP. These cells were present in and around the plaque cap and in areas of plaque hemorrhage. For unstable plaques, the mean semiquantitative bAPP score was 1.9 and for stable plaques it was 0.6 (p<0.0001) Correlation coefficients were determined for semiquantitative bAPP scoring versus percent of soft/necrotic plaque component (r=0.57, p<0.0001), thickness of fibrous cap (r=0.14, p=.31), and cap inflammation (r=0.34, p=0.012). Conclusions: This preliminary study is the first to show accumulation of non-amyloid bAPP within carotid plaques and demonstrate an association with at least some specific features of plaque instability. Whether bAPP accumulation has mechanistic significance beyond plaque inflammation and instability remains to be determined and needs further study.
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Implementation of the New AECVP/SCVP Aorta Consensus Grading Scheme Kevin Waters, Andrew Guajardo, Marc K Halushka. Johns Hopkins University SOM, Baltimore, MD. Background: The Association for European Cardiovascular Pathology (AECVP) and the Society for Cardiovascular Pathology (SCVP) have developed a new consensus nomenclature and grading scheme for degenerative, noninflammatory thoracic aortic specimens in order to improve the consistency of diagnosis for this specimen type. We tested the usability of these new terms on routine surgical pathology aorta cases. Design: 100 consecutive noninflammatory aortic specimens and basic phenotypic data were obtained from the surgical archives. After an initial general review of aortic histopathology with two trainees and one cardiovascular pathologist, each case was independently scored by two observers in a blinded fashion for 13 features using H&E and Movat stained slides. All data was categorized, converted into numbers, tabulated and analyzed using a Mann Whitney U test. Results: There was strong overall consensus on the overarching diagnosis of medial degeneration with only 3 of 100 cases demonstrating two levels of disagreement. There was more variability in the usage of less common findings such as elastic fiber thinning. Forty-seven cases had a known genetic syndrome (bicuspid aortic valve (BAV), Marfan, Loeys Dietz, FTAAD), with an average age of 42. The average age of the non-syndromic cases was 63. There was significantly less overall medial degeneration in subjects with BAV (n=31) than in the other syndromic cases (p=2.2x10 -3 ). Among the non-syndromic cases, overall medial degeneration increased with age. This was the result of increasing amounts of smooth muscle cell nuclear loss, laminar medial collapse and mucoid extracellular matrix accumulation (MEMA).
Conclusions:
The new AECVP/SCVP Aorta Consensus Grading Scheme is a robust method for general surgical pathology signout and research studies. New, less common terminology will require increasing familiarity for consistent implementation. A new uniformity between centers can now be accomplished. Even within a small study set, we uncovered significant differences associated with syndromes and aging. With increasing use and larger study sets, it may now be possible to associate histopathologic findings with specific syndromes and increase the value of the surgical thoracic aorta.
Cytopathology
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Can the Ki-67 Index Evaluated on Fine Needle Aspiration Cellblock Material Reliably Grade Pancreatic Neuroendocrine Tumors? Rita Abi Raad, Andrea L Barbieri, Xuchen Zhang, Malini Harigopal, Rebecca Baldassarri, Angelique W Levi, Susan V Fernandez, Diane Kowalski, Adebowale Adeniran, Guoping Cai. Yale School of Medicine, Nerw Haven, CT. Background: Currently, the best predictor of pancreatic neuroendocrine tumor (PNET) behavior is the tumor grade determined by measuring mitotic activity or/and Ki-67 index on surgically resected specimens. Although fine needle aspiration (FNA) is widely used in the preoperative diagnosis of PNETs, its role in prognostic evaluation of the tumors is very limited. The goal of this study was to assess the tumor grade, as determined by the Ki-67 index, on FNA cellblock material and correlate with the final grade on resection specimens. Design: The institutional pathology database was searched for PNETs diagnosed by FNA between January 2006 and August 2015. Only the cases with available cellblock material and corresponding surgical specimens were included in the study. Clinicopathologic characteristics, cytological and surgical follow-up cases were retrospectively reviewed. The cytological diagnosis of PNETs was rendered by cytomorphologic analysis and adjunctive chromogranin and synaptophysin immunostains. Surgically resected tumors were graded according to 2010 WHO classification and staged following 2010 AJCC staging criteria. Ki-67 immunostain was retrospectively performed on FNA cellblocks and resected tumors if not performed initially. Results: A total of 48 FNA cases with corresponding resections were identified. The cellblock sections contained >1000, 500-1000, 250-500, 100-250, and <100 tumor cells in 23, 9, 10, 2 and 4 cases, respectively. The resected tumors ranged from 0.9 to 8.5 cm (mean = 3.2 cm) and were graded as G1 and G2 tumors in 24 and 24 cases, respectively. In G1 tumors, the Ki-67 grading based on cellblock sections showed a 100% correlation rate with the grading on surgical specimens, regardless of cellblock cellularity and tumor size. However, in G2 tumors the correlation rate between cellblocks and surgical
